New COPD drug candidate tested for safety in healthy volunteers
Disease control
Completed
This completed Phase 1 trial tested the safety of Hemay005 tablets, a potential new drug for chronic obstructive pulmonary disease (COPD), in 468 healthy Chinese adults. Researchers compared different dosing methods (titration vs. non-titration) to see how they affect side effect…
Phase: PHASE1 • Sponsor: Anhui Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC